International Clinical Trial: Effects of Inhaled Treprostinil on Exercise Performance in Exercise Induced Pulmonary Hypertension

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07116681) titled 'Effects of Inhaled Treprostinil on Exercise Performance in Exercise Induced Pulmonary Hypertension' on Aug. 7.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: University of California, San Diego

Condition: Pulmonary Hypertension

Intervention: Drug: Inhaled treprostinil

Recruitment Status: Not recruiting

Phase: Early Phase 1

Date of First Enrollment: August 1, 2025

Target Sample Size: 8

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07116681

Published by HT Digital...